Activation of Notch1 signaling by marrow-derived mesenchymal stem cells through cell-cell contact inhibits proliferation of hepatic stellate cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Life Science

• Publication date

  2011-12-19

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.lfs.2011.10.012PMID 22056375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nerve growth factor-mediated paracrine regulation of hepatic stellate cells by multipotent mesenchymal stromal cells.

  2009cited by this paper
• The niche of stellate cells within rat liver

  2009cited by this paper
• Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats

  2009cited by this paper
• Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis.

  2009cited by this paper
• Modeling the segmentation clock as a network of coupled oscillations in the Notch, Wnt and FGF signaling pathways.

  2008cited by this paper
• Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.

  2008cited by this paper
• Hedgehog-mediated paracrine interaction between hepatic stellate cells and marrow-derived mesenchymal stem cells.

  2008cited by this paper
• Cell‐Cell Signaling Through NOTCH Regulates Human Embryonic Stem Cell Proliferation

  2008cited by this paper
• Hepatocyte-Like Cells from Human Mesenchymal Stem Cells Engrafted in Regenerating Rat Liver Tracked with In Vivo Magnetic Resonance Imaging

  2008cited by this paper
• Notch Signaling Through Jagged‐1 Is Necessary to Initiate Chondrogenesis in Human Bone Marrow Stromal Cells but Must Be Switched off to Complete Chondrogenesis

  2008cited by this paper
• Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.

  2007cited by this paper
• Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.

  2007cited by this paper
• Crossing paths with Notch in the hyper-network.

  2007cited by this paper
• Bone marrow–derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice

  2007cited by this paper
• Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers

  2006cited by this paper
• Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.

  2006cited by this paper
• Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats.

  2006cited by this paper
• Overexpression of the NOTCH1 Intracellular Domain Inhibits Cell Proliferation and Alters the Neuroendocrine Phenotype of Medullary Thyroid Cancer Cells*

  2006cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.

  2005cited by this paper
• Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21Cip1 Repression

  2004cited by this paper
• Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.

  2004cited by this paper
• Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.

  2004cited by this paper
• Transplantation of bone marrow cells reduces CCl4‐induced liver fibrosis in mice

  2004cited by this paper
• Systemic Infusion of FLK1+ Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis in Mice

  2004cited by this paper
• Liver fibrosis -- from bench to bedside.

  2003cited by this paper
• Transplanted bone marrow regenerates liver by cell fusion

  2003cited by this paper
• Regulation of Notch1 and Dll4 by Vascular Endothelial Growth Factor in Arterial Endothelial Cells: Implications for Modulating Arteriogenesis and Angiogenesis

  2003cited by this paper
• The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.

  2002cited by this paper
• Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

  2000cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• The study of apoptotic cells by flow cytometry

  1998cited by this paper

• Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?

  2025cites this paper
• Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells

  2025cites this paper
• Engineered mesenchymal stem cell-derived exosomes: A revolutionary approach to unlocking liver disease treatment

  2025cites this paper
• Modulation of Notch signaling pathway in activated hepatic stellate cells does not ameliorate the outcome of liver fibrosis in carbon tetrachloride and DDC-feeding models

  2024cites this paper
• Cell therapy for end-stage liver disease: Current state and clinical challenge

  2024cites this paper
• Therapeutic Role of Bone Marrow Mesenchymal Stem Cells (BMSCs) in Nonalcoholic Steatohepatitis (NASH) Cirrhosis.

  2024cites this paper
• Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism

  2024cites this paper
• Exosomal therapy is a luxury area for regenerative medicine.

  2024cites this paper
• A comprehensive meta-analysis of stem cell therapy for liver failure: Assessing treatment efficacy and modality.

  2024cites this paper
• Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis.

  2024cites this paper
• TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation

  2024cites this paper
• Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease

  2023cites this paper
• Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment

  2023cites this paper
• Therapeutic and Safety Promise of Mesenchymal Stem Cells for Liver Failure: from Preclinical Experiment to Clinical Application.

  2023cites this paper
• Liver fibrosis in fish research: From an immunological perspective.

  2023cites this paper
• The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis

  2023cites this paper
• Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway

  2023cites this paper
• Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis

  2022cites this paper
• Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease

  2022cites this paper
• Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Agent for the Treatment of Liver Diseases

  2022cites this paper
• Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review

  2022cites this paper
• Regulatory Effect of Mesenchymal Stromal Cells on the Development of Liver Fibrosis: Cellular and Molecular Mechanisms and Prospects for Clinical Application

  2021cites this paper
• The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs

  2021cites this paper
• Effect of mesenchymal stem cell in liver regeneration and clinical applications

  2021cites this paper
• Bone Marrow-derived Mesenchymal Stem Cells Reverse Hepatic Fibrosis, Improved Vascularity, and Attenuate the Apoptosis in Carbon Tetrachloride-induced Hepatic Fibrosis Experimental Rats

  2021cites this paper
• Stem Cell-based Therapy Strategy for Hepatic Fibrosis by Targeting Intrahepatic Cells

  2021cites this paper
• Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis

  2021cites this paper
• Regulatory Effect of Mesenchymal Stromal Cells on the Development of Liver Fibrosis: Cellular and Molecular Mechanisms and Prospects for Clinical Application

  2021influential citation
• Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases

  2021cites this paper
• Cell Therapy for Liver Disease: From Promise to Reality

  2020cites this paper
• A brief analysis of mesenchymal stem cells as biological drugs for the treatment of acute-on-chronic liver failure (ACLF): safety and potency.

  2020cites this paper
• [Liver regeneration after resection in clinical and experimental conditions].

  2020cites this paper
• Favorable outcome of adjunctive traditional Chinese medicine therapy in liver cirrhosis: A large cohort study in Southwest China.

  2020cites this paper
• Locoregional delivery of stem cell–based therapies

  2020cites this paper
• Mesenchymal stem cell therapy for liver disease: full of chances and challenges

  2020cites this paper
• The role of stem cells in liver injury and repair

  2019cites this paper
• Adipose tissue‐derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL‐17‐mediated inflammation

  2019cites this paper
• Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview

  2019cites this paper
• Stem Cell Transplant for Advanced Stage Liver Disorders: Current Scenario and Future Prospects.

  2019cites this paper
• Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives

  2019cites this paper
• Umbilical cord blood stem cells transplantation as an adjunctive treatment strategy for liver cirrhosis in Chinese population: a meta-analysis of effectiveness and safety

  2018cites this paper
• Mesenchymal stromal cell therapy for liver diseases.

  2018influential citation
• Activation of Hes1 and Msx1 in Transgenic Mouse Embryonic Stem Cells Increases Differentiation into Neural Crest Derivatives

  2018cites this paper
• NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation

  2018cites this paper
• Novel Insights on Notch signaling pathways in liver fibrosis

  2018cites this paper
• Bone Marrow Stem Cells Anti-liver Fibrosis Potency: Inhibition of Hepatic Stellate Cells Activity and Extracellular Matrix Deposition

  2017cites this paper
• Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases

  2017cites this paper
• Smad7-overexpressing rat BMSCs inhibit the fibrosis of hepatic stellate cells by regulating the TGF-β1/Smad signaling pathway

  2017cites this paper
• Bronchopulmonary Dysplasia: Where Have All the Stem Cells Gone?: Origin and (Potential) Function of Resident Lung Stem Cells

  2017cites this paper
• Notch in fibrosis and as a target of anti-fibrotic therapy.

  2016cites this paper
• Mesenchymal stromal cells and liver fibrosis: a complicated relationship

  2016cites this paper
• CXCR 4-transduced bone marrow mesenchymal stem cells contribute to liver regeneration in cirrhotic rats through the transplant microenvironment

  2016cites this paper
• Mesenchymal stem cell therapy for liver fibrosis

  2015cites this paper
• Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.

  2015cites this paper
• Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis.

  2014cites this paper
• Curcumin attenuates endothelial cell oxidative stress injury through Notch signaling inhibition.

  2013cites this paper
• Myofibroblasts

  2013cites this paper
• Cross‐talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice

  2013cites this paper